TGFB2 and neoplasm: None of the TGFB2 receptors exhibited a lower expression level in tumor samples from non-DIPG DMG patients (N = 19) compared to the tumor samples from DIPG patients (N = 41) to explain the observed lack of prognostic significance of higher TGFB2 mRNA levels in this patient group (Figure S6).